Replies to post #10153 on OncoSec Medical Inc (ONCSQ)

[W&T Capital LLC]

According to Punit MCC was to complete enrollment by end of this quarter. This is what he said at the Wall Street Forum Conference. But you guys know more about this stuff than me so I listen. But how many they had enrolled by end of January is anyone's guess.

[trebor4]

I am sorry lasers but that is not an option. Straight from ASGCT if the presentation is not going to be NEW data then they would not have offered a spot. This is straight from them, the presentation at ASGCT will be NEW data for Melanoma Phase 1 and 2. If you combine that with ASCO's strict policy for confidentiality there is no way to present NEW data on May 22 and then have enough NEW data for a week later at ASCO. Never mind that unless the data was in hand when they submitted the abstract to ASCO, they could not submit for it. So, unless the two reps for ASGCT that I spoke with today are wrong, Melanoma will not be at ASCO. If you can find a way around all this have at it, I would love to hear it, but as of yet there has been NO scenario presented that would have Melanoma presenting at ASCO.

[erostratus]

I hear you dude,
But now I just don't see what new data we would have had as off Jan 2014 for melanoma. The interim results were made public in december. i dont see additional data being available by abstract submission date. long term pfs data for p1 was already made public.

As to MCC, enrollment does not have to be complete for an interim analysis to be presented. Something substantial could have happened with the existing participants.

We'll just have to see though.